Why BGPT?
logo

Paper Review β€” Claim-Level

Inspect each claim in a paper alongside its supporting experiments, exact results, and falsification criteria for rigorous review.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review


     Quick Explanation



    This preprint provides in vitro evidence that coculture of C. aerofaciens and B. thetaiotaomicron under 300 Β΅M deoxycholic acid (DCA) stress reduces B. theta growth inhibition from 58% to 32%, likely through C. aerofaciens DCA sequestration and vitamin B6/PLP cross-feeding .


     Long Explanation



    Evidence Summary and Critical Analysis

    The paper reports that under 300 Β΅M DCA, B. thetaiotaomicron monoculture OD600 dropped 58%, while coculture with C. aerofaciens limited this to 32% . LC-MS/MS confirmed reduced extracellular DCA with C. aerofaciens, consistent with uptake/bioaccumulation, though mass balance was imperfect (~400 Β΅M total vs 300 Β΅M nominal) and only trace gDCA was detected. Proteomics (4,237 B. theta and 2,537 C. aerofaciens proteins) showed coculture upregulated pdxS/pdxT (PLP synthase) in C. aerofaciens with increased extracellular PLP; B. thetaiotaomicron lacks genomic support for pdxS/pdxT. Exogenous PLP promoted B. theta growth at 50 ng/L but inhibited it at β‰₯100 ng/L .

    Limitations: mass balance inconsistencies, no explicit biological replicate N, no isotope flux tracing, purely in vitro two-species system, and C. aerofaciens growth was actually reduced in coculture suggesting nutrient competition rather than pure mutualism. The narrow PLP dose-response window constrains extrapolation to host vitamin B6 supplementation.



    Feedback:   

    Updated: September 07, 2026

    BGPT Paper Review



    Study Novelty

    80%

    First demonstration of vitamin B6/PLP exchange between C. aerofaciens and B. thetaiotaomicron under bile acid stress; bile-acid-mediated microbial cross-feeding is emerging but underexplored.



    Scientific Quality

    60%

    Multi-omics with targeted validation is solid for a preprint, but lacks explicit replicate numbers, DCA mass-balance inconsistencies, no flux tracing, and purely in vitro scope.



    Study Generality

    40%

    Findings are specific to a two-species BHIS system at one DCA concentration; generalization to complex gut communities or other bile acids is untested.



    Study Usefulness

    50%

    Provides a concrete mechanistic hypothesis (DCA sequestration + PLP cross-feeding) for future in vivo testing and identifies B6 as a potential modulator of bile acid tolerance.



    Study Reproducibility

    80%

    Strain IDs, culture conditions, proteomics (PRIDE PXD069395), metabolomics (Metabolomics Workbench), and R scripts on Zenodo/GitHub are publicly deposited.



    Explanatory Depth

    60%

    Genomic annotation and proteomics support PLP cross-feeding, but the DCA-uptake mechanism is inferred from mass balance without transporter ID or isotope flux confirmation.

     Top Data Sources ExportMCP



     Analysis Wizard



    Comparing PLP pathway gene completeness between C. aerofaciens and B. thetaiotaomicron using gapseq annotations from the paper to validate the cross-feeding genomic basis.



     Hypothesis Graveyard



    That C. aerofaciens actively biotransforms DCA into less toxic conjugates as its primary protective mechanismβ€”rejected because total DCA mass balance was inconsistent and gDCA was detected only at trace levels, favouring bioaccumulation instead.


    That PLP supplementation is uniformly beneficial for B. thetaβ€”falsified by the β‰₯100 ng/L cytotoxic range, showing a narrow therapeutic window.

     Science Art


    Paper Review: Coculture of                  Collinsella aerofaciens                  and                  Bacteroides thetaiotaomicron                  under bile acid stress reveals vitamin B6 exchange Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT